Geographic Area – Page 23

Merck KGaA Evades Legal Action Following DOJ Collaboration on China Export Investigation

11 months ago talkbio0Tagged Avoidance, China, cooperation, DOJ, Evaluation, Export, Imprisonment (finding), Merck KGaA

Merck KGaA, DOJ, China, export scheme, cooperation, investigation, prosecution avoidance

Evotec Discontinues Gene Therapy Operations, Shuts Down Austria Facility

11 months ago talkbio0Tagged Austria, Biotechnology, business operations, development aspects, Evotec, Facility (object), gene therapy, Reparative closure, research, strategic decision

Evotec, gene therapy, Austria, facility closure, strategic decision, business operations, research and development, biotechnology

AstraZeneca Invests $1.5 Billion in Singapore for Comprehensive Antibody-Drug Conjugate Manufacturing

11 months ago talkbio0Tagged Antibody-Drug Conjugates, AstraZeneca, Biotechnology, Cancer Therapeutic Procedure, end-to-end, Investments, Manufacture, production, Singapore

AstraZeneca, Singapore, antibody-drug conjugate (ADC), manufacturing, investment, biotechnology, pharmaceuticals, end-to-end production, cancer treatment.

AstraZeneca’s Ambitious Vision: Pursuing $80 Billion in Revenue and 20 New Drugs by 2030

11 months ago talkbio0Tagged AstraZeneca, Biotechnology, Drug Development, Drug Industry, expansion, growth strategy, healthcare innovation, Market

AstraZeneca, revenue target, new drugs, 2030, growth strategy, pharmaceutical industry, healthcare innovation, biotechnology, drug development, market expansion.

Progentos Secures $65 Million for Groundbreaking Remyelination Therapy in Multiple Sclerosis Treatment

11 months ago talkbio0Tagged Biotechnology, Clinical Trials, Mississippi (geographic location), Multiple Sclerosis, nervous system repair, Neurodegenerative Disorders, Progentos, Remyelination

Progentos, funding, remyelination therapy, multiple sclerosis, MS treatment, clinical trials, neurodegenerative diseases, nervous system repair, biotechnology.

Legislators Profit from Bill Restricting Chinese Biotech Firms

11 months ago talkbio0Tagged China, Conflict (Psychology), Congress (U.S. Legislature), financial gain, Influence, legislative, trading

Congress, stock trading, China biotech ban, financial gain, legislative influence, conflict of interest.

AstraZeneca Invests $1.5 Billion in Singapore for State-of-the-art Antibody-Drug Conjugate Manufacturing Facility

11 months ago talkbio0Tagged Antibody-Drug Conjugates, AstraZeneca, Biotechnology, Cancer Therapeutic Procedure, end-to-end, expansion, Facility (object), Generalized, innovation, Investments, Singapore

AstraZeneca, Singapore, investment, antibody-drug conjugate (ADC), manufacturing facility, end-to-end production, biotechnology, pharmaceuticals, cancer treatment, innovation, global expansion.